|
Ache |
acetylcholinesterase |
|
ADI |
acceptable daily intake |
|
AFI(D) |
alkali flame-ionization (detector) |
|
ai |
active ingredient |
|
ALAT |
alanine aminotransferase |
|
approx. |
approximate |
|
ASAT |
aspartate aminotransferase |
|
|
|
|
BBA |
Biologische Bundesanstalt für Land- und Forstwirtschaft |
|
bw (not b.w.) |
body weight |
|
|
|
|
c |
centi- (x 10-2) |
|
CA |
Chemical Abstracts |
|
CAS |
Chemical Abstracts Services |
|
CCN |
Codex Classification Number (this may refer to classification numbers for compounds or for commodities). |
|
CCPR |
Codex Committee on Pesticide Residues |
|
ChE |
cholinesterase |
|
CNS |
central nervous system |
|
cv |
coefficient of variation |
|
CXL |
Codex Maximum Residue Limit (Codex MRL). See MRL. |
|
|
|
|
DFG |
Deutsche Forschungsgemeinschaft |
|
DL |
racemic (optical configuration, a mixture of dextro- and laevo-) |
|
DP |
dustable powder |
|
DS |
powder for dry seed treatment |
|
|
|
|
EBDC |
ethylenebis (dithiocarbamate) |
|
EC |
(1) emulsifiable concentrate |
|
|
(2) electron-capture [chromatographic detector] |
|
ECD |
electron-capture detector |
|
EMDI |
estimated maximum daily intake |
|
EPA |
Environmental Protection Agency |
|
ERL |
extraneous residue limit |
|
ETU |
ethylenethiourea |
|
|
|
|
F1 |
filial generation, first |
|
F2 |
filial generation, second |
|
f.p. |
freezing point |
|
FAO |
Food and Agriculture Organization of the United Nations |
|
FDA |
Food and Drug Administration |
|
FID |
flame-ionization detector |
|
FPD |
flame-photometric detector |
|
|
|
|
g (not gm) |
gram |
|
m g |
microgram |
|
GAP |
good agricultural practice(s) |
|
GC-MS |
gas chromatography - mass spectrometry |
|
G.I. |
gastrointestinal |
|
GL |
guideline level |
|
GLC |
gas-liquid chromatography |
|
GLP |
Good Laboratory Practice |
|
GPC |
gel-permeation chromatography |
|
GSH |
glutathione |
|
|
|
|
h (not hr) |
hour(s) |
|
ha |
hectare |
|
Hb |
haemoglobin |
|
hl |
hectolitre |
|
HPLC |
high-performance liquid chromatography |
|
HPLC-MS |
high-performance liquid chromatography - mass spectrometry |
|
|
|
|
IBT |
Industrial Bio-Test Laboratories |
|
i.d. |
internal diameter |
|
i.m. |
intramuscular |
|
i.p. |
intraperitoneal |
|
IPCS |
International Programme on Chemical Safety |
|
IR |
infrared |
|
IRDC |
International Research and Development Corporation (Mattawan, Michigan, USA) |
|
i.v. |
intravenous |
|
|
|
|
JMPR |
Joint FAO/WHO Meeting on Pesticide Residues (Joint Meeting of the FAO Panel of Experts on Pesticide Residues) in Food and the Environment and the WHO Core Assessment Group |
|
|
|
|
LC |
liquid chromatography |
|
LC50 |
lethal concentration, 50% |
|
LC-MS |
liquid chromatography - mass spectrometry |
|
LD50 |
lethal dose, median |
|
LOAEL |
lowest observed adverse effect level |
|
LOD |
limit of determination (see also "*" at the end of the Table) |
|
LSC |
liquid scintillation counting or counter |
|
|
|
|
MFO |
mixed function oxidase |
|
mm |
micrometre (micron) |
|
min |
minute(s) |
|
MLD |
minimum lethal dose |
|
M |
molar |
|
mo (not mth.) |
month(s) |
|
MRL |
Maximum Residue Limit. MRLs include draft MRLs and Codex MRLs (CXLs). The MRLs recommended by the JMPR on the basis of its estimates of maximum residue levels enter the Codex procedure as draft MRLs. They become Codex MRLs when they have passed through the procedure and have been adopted by the Codex Alimentarius Commission. |
|
MS |
mass spectrometry |
|
MTD |
maximum tolerated dose |
|
|
|
|
n |
normal (defining isomeric configuration) |
|
NCI |
National Cancer Institute (United States) |
|
NMR |
nuclear magnetic resonance |
|
NOAEL |
no-observed-adverse-effect level |
|
NOEL |
no-observed-effect level |
|
NP(D) |
nitrogen-phosphorus (detector) |
|
NTE |
neuropathy target esterase |
|
|
|
|
OP |
organophosphorus pesticide |
|
|
|
|
PHI |
pre-harvest interval |
|
ppm |
parts per million. (Used only with reference to the concentration of a pesticide in an experimental diet. In all other contexts the terms mg/kg or mg/l are used). |
|
PT |
prothrombin time |
|
PTDI |
provisional tolerable daily intake. (See 1994 report, Section 2.3, for explanation) |
|
PTT |
partial thromboplastin time |
|
PTU |
propylenethiourea |
|
|
|
|
RBC |
red blood cell |
|
|
|
|
s.c. |
subcutaneous |
|
SC |
suspension concentrate (= flowable concentrate) |
|
SD |
standard deviation |
|
SE |
standard error |
|
SG |
water-soluble granule |
|
SL |
soluble concentrate |
|
SP |
water-soluble powder |
|
sp./spp. |
species (only after a generic name) |
|
sp gr (not sp. gr.) |
specific gravity |
|
STMR |
supervised trials median residue |
|
|
|
|
t |
tonne (metric ton) |
|
T3 |
tri-iodothyronine |
|
T4 |
thyroxine |
|
TADI |
Temporary Acceptable Daily Intake |
|
tert |
tertiary (in a chemical name) |
|
TLC |
thin-layer chromatography |
|
TMDI |
theoretical maximum daily intake |
|
TMRL |
Temporary Maximum Residue Limit |
|
TPTA |
triphenyltin acetate |
|
TPTH |
triphenyltin hydroxide |
|
TSH |
thyroid-stimulating hormone (thyrotropin) |
|
|
|
|
UDMH |
1,1-dimethylhydrazine (unsymmetrical dimethylhydrazine) |
|
USEPA |
United States Environmental Protection Agency |
|
USFDA |
United States Food and Drug Administration |
|
UV |
ultraviolet |
|
|
|
|
v/v |
volume ratio (volume per volume) |
|
|
|
|
WG |
water-dispersible granule |
|
WHO |
World Health Organization |
|
WP |
wettable powder |
|
wt/vol |
weight per volume |
|
w/w |
weight ratio (weight per weight) |
|
|
|
|
< |
less than |
|
£ |
less than or equal to |
|
> |
greater than |
|
³ |
greater than or equal to |
|
* |
(following residue levels, e.g. 0.01* mg/kg): level at or about the limit of determination |
